Resultaterne af denne undersøgelse er derfor et vidnesbyrd om, at det aktuelle produkt giver det forventede niveau af beskyttende antistoffer hos alle de populationer, det er indiceret til.
Therefore, the results of this study provide evidence that the currently available product is providing the expected level of protective antibodies in all populations for which it is indicated.